China
Fudan University - Department of Oncology
Cancer of unknown primary, clinicopathological characteristics, molecular feature, prognostic model, survival
ESR1 mutation, Hormone receptor-positive breast cancer, HER2-negative breast cancer, Selective estrogen receptor degrader (SERD), Meta-analysis
Cancer of unknown primary, 90-gene assay, Putative primary site, Multidisciplinary team, TNM staging